After 3 failures in quick succession, it is time for a massive wage cut and make some positions redundant.
What will happen to the excess stocks and our contract with Lonza, our debt with Hercules Capital and will Novartis walk?
Every time there is bad news management likes to hide behind the trading halt and it is no different this time around again. People give the CEO too much credit when the company haven't accomplished anything substantial after raising 1 billion from Investors in 15+ years.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-615
-
- There are more pages in this discussion • 461 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
0.030(2.71%) |
Mkt cap ! $1.295B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.14 | $1.08 | $2.723M | 2.463M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2734 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 231633 | 23 |
View Market Depth
| Last trade - 14.25pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |